New EDS Research Center: Baltimore Location Announced
The Center for Clinical Care and Research is officially underway. The EDNF will partner to create a virtual center at the Greater Baltimore Medical Center (GBMC) under the direction of Dr. Clair Francomano. The partnership agreement was signed on May 8, 2013.
McLean, VA (PRWEB) May 14, 2013
Ehlers-Danlos National Foundation (EDNF) will provide funding to support a virtual center at Greater Baltimore Medical Center (GBMC) under the direction of Clair Francomano, MD, GBMC’s Director of Adult Genetics. The Center will provide comprehensive clinical care for patients, professional education for physicians and a research component. Elliot Clark, EDNF board chairman, and Shane Robinson, EDNF executive director, were on hand at GBMC on Wednesday, May 8 to formally sign an agreement officially announcing the partnership between EDNF and GBMC.
“Partnering with the Greater Baltimore Medical Center to open the first ever EDNF Center for Clinical Care and Research is an exciting new initiative for the foundation,” said Shane Robinson, EDNF executive director. “EDS often goes undiagnosed because physicians are not aware of the disease. The funding EDNF is providing to establish this clinic is a major step forward in advancing our mission to educate healthcare practitioners and patients and provide treatment to help people living with EDS.”
Clinical research, education, and treatment for Ehlers–Danlos syndrome (EDS), a group of inherited connective tissue disorders for which there is no cure, took a significant step forward on May 8 with the establishment of the first ever Ehlers-Danlos National Foundation Center for Clinical Care and Research at GBMC’s Harvey Institute for Human Genetics. May is Ehlers-Danlos Syndrome Awareness Month, and the disease is believed to affect about one in 2,500 to one in 5,000 individuals worldwide.
“We are extremely grateful to EDNF for their support which will allow us to explore new treatment options for patients and raise awareness among physicians. It is our hope that these efforts will lead to earlier diagnosis and better treatment options for patients with EDS, and provide the opportunity for continued research into the causes of EDS,” said Dr. Francomano. “Knowledge concerning the underlying causes of the disease will enable us to seek rationale therapies for this complex and disabling condition.”
About Ehlers-Danlos National Foundation (EDNF): EDNF is the leading authority for Ehlers-Danlos Syndrome (EDS), a group of genetic connective tissue disorders. To support research and education about EDS to prevent disfigurement, crippling, and premature death through early and accurate diagnosis, EDNF increases awareness about EDS by fostering and funding research, generating and distributing accurate and responsible information, and delivering recommendations for those seeking diagnosis of problems that have been a life-long mystery. EDNF also provides support to those who have been diagnosed with EDS by offering information and emotional validation for the newly diagnosed wrestling with what a genetic disorder means for them and their families, and provides tips for those who have lived with EDS for years, including day-to-day inspiration and news. EDNF’s members are physicians and other medical practitioners, researchers, people with EDS, and friends. For more information, visit http://www.ednf.org.
About Dr. Francomano: Dr. Francomano received her undergraduate degree at Yale University and her medical degree from The Johns Hopkins University School of Medicine. She trained in internal medicine and medical genetics at Johns Hopkins and joined the full-time Hopkins faculty in 1984. She joined GBMC’s Harvey Institute of Human Genetics in 2005. Dr. Francomano is an Associate Professor of Medicine at Johns Hopkins University School of Medicine. She has held positions as Clinical Director and Chief of the Medical Genetics Branch at the National Human Genome Research Institute, National Institutes of Health and Chief of the Human Genetics and Integrative Medicine Section in the Laboratory of Genetics, National Institute on Aging.
Dr. Francomano is board-certified in internal medicine, clinical genetics and clinical molecular genetics. She is a member of the American College of Physicians, the American Society of Human Genetics and the American Society for Clinical Investigation, and is a founding fellow of the American College of Medical Genetics.
In 2008, and every year since, Dr. Francomano has been named among “Baltimore’s Best Medical Geneticists” by Baltimore Magazine. Her clinical and research interests include the hereditary disorders of connective tissue and skeletal dysplasias. She received EDNF’s Shining Star award in 2012 for her dedication to people with EDS.
About GBMC: GBMC HealthCare system includes Greater Baltimore Medical Center, a 270-bed acute care not-for-profit hospital which opened in 1965 and provides “Health, Healing and Hope”; Greater Baltimore Medical Associates, a group of more than 40 multi-specialty physician practices on the hospital’s Towson campus and locations across the region; Greater Baltimore Health Alliance, an alliance of GBMC-employed and private practicing physician partners; Gilchrist Hospice Care, Maryland’s largest hospice organization offering care in-home as well as in a 34-bed inpatient center on the GBMC Towson campus and at a 10-bed inpatient center in Howard County; and the GBMC Foundation, which raises funds to support the organization’s mission. Click here for more information about GBMC.
Click here for the original announcement
Click here to view the announcement on EDNF’s website.
We appreciate your Likes and Comments